Shandong Lukang Pharmaceutical Co Ltd (600789) — Cash Flow-to-Debt Ratio
Shandong Lukang Pharmaceutical Co Ltd (600789) has a Cash Flow-to-Debt Ratio of 0.00x as of September 2025, meaning its operating cash flow of CN¥-6.39 Million could theoretically repay 0% of its total liabilities (CN¥4.71 Billion) in one year. Explore 600789 long-term investments to assets to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Lukang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shandong Lukang Pharmaceutical Co Ltd across 28 annual periods. Also explore Shandong Lukang Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shandong Lukang Pharmaceutical Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shandong Lukang Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Shandong Lukang Pharmaceutical Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥698.17 Million | CN¥4.78 Billion | ▲ +82.7% |
| 2024 | 0.08x | CN¥402.82 Million | CN¥5.04 Billion | ▼ -33.0% |
| 2023 | 0.12x | CN¥604.01 Million | CN¥5.06 Billion | ▲ +40.2% |
| 2022 | 0.09x | CN¥444.38 Million | CN¥5.22 Billion | ▲ +150.3% |
| 2021 | 0.03x | CN¥149.33 Million | CN¥4.39 Billion | ▼ -43.2% |
| 2020 | 0.06x | CN¥234.55 Million | CN¥3.91 Billion | ▼ -35.1% |
| 2019 | 0.09x | CN¥361.87 Million | CN¥3.92 Billion | ▼ -8.0% |
| 2018 | 0.10x | CN¥351.09 Million | CN¥3.50 Billion | ▲ +13.1% |
| 2017 | 0.09x | CN¥275.51 Million | CN¥3.10 Billion | ▼ -34.2% |
| 2016 | 0.13x | CN¥296.23 Million | CN¥2.20 Billion | ▲ +263.6% |
| 2015 | 0.04x | CN¥78.39 Million | CN¥2.11 Billion | ▼ -11.8% |
| 2014 | 0.04x | CN¥108.56 Million | CN¥2.58 Billion | ▼ -60.0% |
| 2013 | 0.11x | CN¥256.50 Million | CN¥2.44 Billion | ▲ +117.0% |
| 2012 | 0.05x | CN¥115.20 Million | CN¥2.38 Billion | ▼ -29.8% |
| 2011 | 0.07x | CN¥123.28 Million | CN¥1.79 Billion | ▼ -69.9% |
| 2010 | 0.23x | CN¥308.88 Million | CN¥1.35 Billion | ▲ +6.8% |
| 2009 | 0.21x | CN¥199.49 Million | CN¥930.38 Million | ▲ +2.5% |
| 2008 | 0.21x | CN¥209.39 Million | CN¥1.00 Billion | ▲ +59.8% |
| 2007 | 0.13x | CN¥137.30 Million | CN¥1.05 Billion | ▲ +134.3% |
| 2006 | 0.06x | CN¥56.24 Million | CN¥1.01 Billion | ▼ -62.4% |
| 2005 | 0.15x | CN¥161.64 Million | CN¥1.09 Billion | ▲ +182.8% |
| 2004 | 0.05x | CN¥63.24 Million | CN¥1.20 Billion | ▼ -66.0% |
| 2003 | 0.15x | CN¥167.42 Million | CN¥1.08 Billion | ▼ -46.0% |
| 2002 | 0.29x | CN¥315.59 Million | CN¥1.10 Billion | ▲ +29.1% |
| 2001 | 0.22x | CN¥270.43 Million | CN¥1.22 Billion | ▲ +1031.5% |
| 2000 | 0.02x | CN¥22.36 Million | CN¥1.14 Billion | ▼ -61.3% |
| 1999 | 0.05x | CN¥35.12 Million | CN¥691.92 Million | ▼ -52.1% |
| 1998 | 0.11x | CN¥46.18 Million | CN¥435.91 Million | — |